NishantTagejaMD

PubMed

• 1 citations
  Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES...
  Jennifer L Steel, Charles J George, Lauren Terhorst, Jonathan G Yabes, Vincent Reyes, Dan P Zandberg, Marci Nilsen, Gauri Kiefer, Jonas Johnson, Christopher Marsh, Jas...> ;Lancet. 2024 Apr 6
• 9 citations
  Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering ...
  Dickran Kazandjian, Elizabeth M. Hill, Alexander Dew, Candis Morrison, Joseph Roswarski, Neha Korde, Michael Emanuel, Ani Petrosyan, Manisha Bhutani, Katherine R. Calv...> ;JAMA Oncology. 2021 Nov 1
• 11 citations
  Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with m...
  Nishant Tageja, Neha Korde, Dickran Kazandjian, Sandhya R. Panch, Elisabet E. Manasanch, Manisha Bhutani, Mary Kwok, Sham Mailankody, Constance M. Yuan, Maryalice Stet...> ;Bone Marrow Transplantation. 2018 May 4
• 14 citations
  Host-related immunodeficiency in the development of multiple myeloma.
  Talib Dosani, Sham Mailankody, Neha Korde, Elisabet E. Manasanch, Manisha Bhutani, Nishant Tageja, Mark Roschewski, Mary Kwok, Dickran Kazandjian, Rene Costello, Debra...> ;Leukemia & Lymphoma. 2018 May 4
• 4 citations
  Hepatotoxicity Associated With Vismodegib.
  Manoj P Rai, Nishant Tageja, Heather Laird-Fick, Prabhjot Singh Bedi> ;BMJ Case Reports. 2018 Feb 8
• 31 citations
  Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
  Sham Mailankody, Dickran Kazandjian, Neha Korde, Mark Roschewski, Elisabet E. Manasanch, Manisha Bhutani, Nishant Tageja, Mary Kwok, Yong Zhang, Adriana Zingone, Laure...> ;Blood Advances. 2017 Oct 10
• 13 citations
  Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease
  Jonathan N. Hofmann, Sham Mailankody, Neha Korde, Ye Wang, Nishant Tageja, Rene Costello, Adriana Zingone, Malin Hultcrantz, Michael Pollak, Mark P. Purdue, Ola Landgren> ;Obesity. 2017 Jun 11
• 10 citations
  Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone
  Elisabet E. Manasanch, Carlos Fernández de Larrea, Adriana Zingone, Seth M. Steinberg, Mary Kwok, Nishant Tageja, Manisha Bhutani, Dickran Kazandjian, Mark Roschewski,...> ;Leukemia & Lymphoma. 2017 Mar 4
• 21 citations
  Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging
  Manisha Bhutani, Baris Turkbey, Esther Tan, Neha Korde, Mary Kwok, Elisabet E. Manasanch, Nishant Tageja, Sham Mailankody, Mark Roschewski, Marcia Mulquin, Ashley Carp...> ;Leukemia & Lymphoma. 2016 Apr 7
• 22 citations
  Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines.
  Nishant Tageja, Hunter Groninger> ;Postgraduate Medical Journal. 2016 Jan 1
• 243 citations
  Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma.
  Neha Korde, Mark Roschewski, Adriana Zingone, Mary Kwok, Elisabet E. Manasanch, Manisha Bhutani, Nishant Tageja, Dickran Kazandjian, Sham Mailankody, Peter Wu, Candis ...> ;JAMA Oncology. 2015 Sep 1
• 8 citations
  High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.
  Miriam E. Mossoba, David Halverson, Roger Kurlander, Bazetta Blacklock Schuver, Ashley Carpenter, Brenna Hansen, Seth M. Steinberg, Syed Abbas Ali, Nishant Tageja, Fra...> ;Clinical Cancer Research. 2015 Jun 12
• 22 citations
  Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulatio...
  Elisabet E. Manasanch, Dalia Salem, Constance M. Yuan, Nishant Tageja, Manisha Bhutani, Mary Kwok, Dickran Kazandjian, George Carter, Seth M. Steinberg, Diamond Zuchli...> ;Leukemia & Lymphoma. 2015 May 1
• 1 citations
  Chemotherapy-Induced Nausea and Vomiting #285
  Nishant Tageja, Hunter Groninger> ;Journal of Palliative Medicine. 2014 Dec 15
• 3 citations
  Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials
  Elisabet E. Manasanch, Neha Korde, Sham Mailankody, Nishant Tageja, Manisha Bhutani, Mark Roschewski, Ola Landgren> ;Haematologica. 2014 Dec 1
• 15 citations
  Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease.
  Adriana Zingone, Weixin Wang, Meghan Corrigan-Cummins, S. Peter Wu, Ryan Plyler, Neha Korde, Mary Kwok, Elisabet E. Manasanch, Nishant Tageja, Manisha Bhutani, Marcia ...> ;Cytokine. 2014 Oct 1
• 99 citations
  A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
  Neha Korde, Mattias Carlsten, Min-Jung Lee, Alex Minter, Esther Tan, Mary Kwok, Elisabet E. Manasanch, Manisha Bhutani, Nishant Tageja, Mark Roschewski, Adriana Zingon...> ;Haematologica. 2014 Jun 1
• 66 citations
  Flow Cytometric Differentiation of Abnormal and Normal Plasma Cells in the Bone Marrow in Patients with Multiple Myeloma and Its Precursor Diseases
  Prashant Tembhare, Constance M. Yuan, David Venzon, Raul C. Braylan, Neha Korde, Elisabet E. Manasanch, Diamond Zuchlinsky, Katherine R. Calvo, Roger Kurlander, Manish...> ;Leukemia Research. 2014 Mar 1
• 15 citations
  MYD88 and beyond: novel opportunities for diagnosis, prognosis and treatment in Waldenström's Macroglobulinemia.
  Ola Landgren, Nishant Tageja> ;Leukemia. 2014 Feb 27
• 21 citations
  The proteasome: mechanisms of biology and markers of activity and response to treatment in multiple myeloma.
  Elisabet E. Manasanch, Neha Korde, Adriana Zingone, Nishant Tageja, Carlos Fernández de Larrea, Manisha Bhutani, Peter Wu, Mark Roschewski, Ola Landgren> ;Leukemia & Lymphoma. 2014 Jan 24
• 13 citations
  Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
  Elisabet E. Manasanch, Raul C. Braylan, Maryalice Stetler-Stevenson, Constance M. Yuan, Verena Gounden, Neha Korde, Nishant Tageja, Manisha Bhutani, Katherine R. Calvo...> ;Leukemia & Lymphoma. 2014 Jan 1
• 4 citations
  Smoldering multiple myeloma: present position and potential promises.
  Nishant Tageja, Elisabet E. Manasanch, Neha Korde, Mary Kwok, Sham Mailankody, Manisha Bhutani, Mark Roschewski, Ola Landgren> ;European Journal of Haematology. 2014 Jan 1
• 15 citations
  Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma
  Jeffrey A. Zonder, Jason Valent, Nishant Tageja, Lois Ayash, Abhinav Deol, Zaid Al-Kadhimi, Judith Abrams, Lawrence G. Lum, Voravit Ratanatharathorn, Joseph P. Uberti,...> ;Supportive Care in Cancer. 2013 Apr 17
• 15 citations
  A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple M...
  Muneer H. Abidi, Rishi Agarwal, Nishant Tageja, Lois Ayash, Abhinav Deol, Zaid Al-Kadhimi, Judith Abrams, Simon Cronin, Marie Ventimiglia, Lawrence G. Lum, Voravit Rat...> ;Biology of Blood and Marrow Transplantation. 2013 Jan 1
• 6 citations
  Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mob...
  Muneer H. Abidi, Nishant Tageja, Lois Ayash, Judith Abrams, Voravit Ratanatharathorn, Zaid Al-Kadhimi, Lawrence G. Lum, Simon Cronin, Marie Ventimiglia, Joseph P. Uberti> ;Supportive Care in Cancer. 2012 Oct 1
• Join now to see all

Lectures

• A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term D... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018